Viviscal Hair Growth Supplement for Men is scientifically formulated with AminoMar C - Marine protein complex. Helps to reduce hair loss and increase hair regrowth in men.
Help to reduce hair loss and increase hair regrowth in men. At Viviscal, we understand hair. Viviscal Man supplements are scientifically formulated for men with the exclusive marine protein complex AminoMar C™ combined with the nutrients Zinc, Vitamin C and Linseed which help to reduce hair loss and increase hair regrowth in men.
Directions
Take 2 tablets daily for a minimum of 3-6 months (1 in the morning and 1 in the evening) taken with water after food. Viviscal tablets are easy to swallow. Do not exceed the recommended daily intake.
Ingredients
Each Tablet contains:
Shark Cartilage (From AminoMar C™) 377mg
Malpighia Glabra (Acerola) Fruit Powder 10.6mg
Equivalent to Ascorbic Acid 1.8mg
Equisetum Arvense (Horsetail) Stem Extact Dry Conc. 30mg
Equiv. Dry Stem 165mg
Linum Ustitatissimum (Flaxseed) Seed Extract Dry Conc. 50mg
Equiv. Dry Seed 3g
Ascorbic Acid (Vitamin C) 29mg
Zinc (as Zinc Oxide) 7.5mg
Contains Crustacean products. Fish products.
Warning
Not to be taken by children, pregnant or breastfeeding women or those who have had a heart attack, surgery or major accident. Do not take in conjunction with other medication unless advised by a healthcare practitioner.
In the event of an allergic reaction, cease use and see your doctor immediately. If symptoms persist, consult your healthcare practitioner.
Keep out of reach of children. Vitamin supplements should not replace a balanced diet. Each tablet is individually sealed. Do not use if seal is cut, torn or broken.
General Safety Information
- Always read the label. Use only as directed.
- Nutritional supplements may only be of assistance if the dietary intake is inadequate.
- Supplements should not be used to replace a healthy balanced diet and adequate physical exercise.
- Keep all medications and supplements out of reach of children.
- If symptoms persist see your healthcare professional.
